123 related articles for article (PubMed ID: 38641473)
1. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
[No Abstract] [Full Text] [Related]
2. MEGF6 prevents sepsis-induced acute lung injury in mice.
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2023 Oct; 123():110727. PubMed ID: 37597402
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].
Zheng XL; Gu WJ; Zhang F; Zhao FZ; Li LZ; Huang HY; Li LJ; Yi YH; Yin HY; Xu J
Int Immunopharmacol; 2023 Dec; 125(Pt A):111076. PubMed ID: 37866976
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
[No Abstract] [Full Text] [Related]
6. Corrigendum to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway" [Int. Immunopharmacol. 81 (2020) 106204].
Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
Int Immunopharmacol; 2022 Mar; 104():108355. PubMed ID: 35058156
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and ameliorates acute lethal sepsis in mice" [Int. Immunopharmacol. 129 (2024) 111615].
Lee DJ; Lee SY; Yi YS
Int Immunopharmacol; 2024 May; 132():111969. PubMed ID: 38575463
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].
Chen L; Li M; Lin Y; Li Y; Liang M; Zeng K
Int Immunopharmacol; 2024 Feb; 128():111577. PubMed ID: 38281885
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
Int Immunopharmacol; 2024 Jun; ():112471. PubMed ID: 38879417
[No Abstract] [Full Text] [Related]
11. Corrigendum to "PAD4 selective inhibitor TDFA protects lipopolysaccharide-induced acute lung injury by modulating nuclear p65 localization in epithelial cells" [Int. Immunopharmacol. 88 (2020) 106923].
Zhao X; Gu C; Wang Y
Int Immunopharmacol; 2023 Dec; 125(Pt B):111185. PubMed ID: 37957096
[No Abstract] [Full Text] [Related]
12. Corrigendum to "GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17" [Int. Immunopharmacol. 129 (2024) 111603].
Zhu W; Wang F; Hu C; Zhao Q; Zhang D; Wang X; Hu B; Li J
Int Immunopharmacol; 2024 May; 132():111914. PubMed ID: 38582738
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
Guo R; Li Y; Han M; Liu J; Sun Y
Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
[No Abstract] [Full Text] [Related]
15. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].
Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT
Int Immunopharmacol; 2024 Jun; ():112543. PubMed ID: 38926074
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway" [Int. Immunopharmacol. 96 (2021) 107566].
Islam J; Shree A; Vafa A; Afzal SM; Sultana S
Int Immunopharmacol; 2023 Jun; 119():110096. PubMed ID: 37095029
[No Abstract] [Full Text] [Related]
17. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466].
Geng H; Zhang H; Cheng L; Dong S
Int Immunopharmacol; 2024 Apr; 131():111873. PubMed ID: 38514302
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells" [Int. Immunopharmacol. 20 (2014) 352-357].
Lu J; Chen B; Li S; Sun Q
Int Immunopharmacol; 2019 Apr; 69():408. PubMed ID: 30755386
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Different roles of bortezomib and ONX 0914 in acute kidney injury" [Int. Immunopharmacol. 82 (2020) 106259].
Zhang XZ; Han F; Ding CG; Dou M; Wang YX; Xue WJ; Ding XM; Zheng J; Xu CX; Tian PX
Int Immunopharmacol; 2024 Jan; 126():111189. PubMed ID: 38012900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
